Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Holders of 5% or more of ORTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Orchard Therapeutics plc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Orchard Therapeutics plc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
21 Schedule 13D and 13G filings on Orchard Therapeutics plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 20, 2023 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Mar 20, 2023 | Ra Capital Management, L.P. | 13GOld format | – | – | – | SEC |
| Feb 13, 2023 | CHI Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Zentree Investments Ltd | 13G/AOld format | – | – | – | SEC |
| Dec 20, 2022 | Zentree Investments Ltd | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Sep 9, 2022 | Zentree Investments Ltd | 13GOld format | – | New | – | SEC |
| May 9, 2022 | Artisan Partners Limited Partnership | 13G/AOld format | – | – | – | SEC |
| Feb 14, 20221:26 PM ET | Federated Hermes, Inc. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | CHI Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2022 | Artisan Partners Limited Partnership | 13G/AOld format | – | – | – | SEC |
| Jun 9, 2021 | Artisan Partners Limited Partnership | 13GOld format | – | New | – | SEC |
| Mar 16, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Orchard Therapeutics plc shares.
No Form 144 notices for Orchard Therapeutics plc are on file.